Modern approach to the diagnosis and treatment of bronchial asthma

Despite significant advances in diagnosis, as well as in the development and introduction into clinical practice of a wide range of new pharmacological drugs for the treatment of bronchial asthma, the incidence and mortality from this common lung pathology has been steadily increasing in recent decades. In developed countries, bronchial asthma affects up to 6% of the population; recent epidemiological studies conducted in Moscow revealed a comparable incidence rate [1].